News
Google News
More headlines & perspectives

J&J expands oncology pipeline with $1 billion Firefly Bio deal

Top news

J&J makes $1B bet on emerging DAC space by netting Firefly Bio

By James Waldron

Johnson & Johnson to Buy Firefly Bio for $1 Billion

By Colin Kellaher

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

By Puyaan Singh & Shinjini Ganguli

All coverage

Johnson & Johnson acquires Firefly Bio for $1 billion

By Colleen Cabili

J&J glows with $1B buyout of Firefly and its degrader platform tech

By Gabrielle Masson

Johnson & Johnson Paying $1B For Oncology Startup Firefly

By Al Barbarino

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

By Puyaan Singh & Shinjini Ganguli

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

By Puyaan Singh & Shinjini Ganguli
Search
Clear search
Close search
Google apps
Main menu